Andy Futreal, PhD – MD Anderson Cancer Center

Slides:



Advertisements
Similar presentations
1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,
Advertisements

2013 Travel Award Recipients Early Career Investigator Travel Award Recipients.
NorTex: Research Collaboration Norway-Texas partnering with Industry Challenges By Dr. Jostein Mykletun, Consul General of Norway in Houston Rice University,
LEADERSHIP. Mission Statement ACTION was established as a voluntary educational initiative to promote the sharing of ideas and support for all persons.
Shared Decision Making: Helping Patients be Partners in Their Care 2009 AHRQ Annual Meeting September 14, 2009.
The SARC Sarcoma SPORE: A Unique Collaborative (Ad)venture Raphael E. Pollock, MD, PhD Department of Surgical Oncology Division of Surgery University of.
C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression Vikas Bhardwaj, PhD,
 HCC STEM INTERNSHIP Roa Sadat. Overview  Benefits of STEM  How I was introduced to Dr. Tineke Berends and the program  My internship experience 
Special Seminar Series
Brief pain inventory. (Reproduced with permission from the University of Texas MD Anderson Cancer Center, Department of Symptom Research, Houston, TX.
Equipment Maintenance Direct $pend Opportunity
Volume 17, Issue 12, Pages (December 2016)
Development and Effectiveness of a Multi-layered
Introduction to Individual
Keynote Speaker: John Condeelis, PhD
Agenda New York Cancer Genomics Research Network Monthly Meeting
Evaluating Quality in Clinical Cancer Research: The M. D
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Immunotherapeutics 18th Annual Research Retreat
Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,
Competition: Perspiration to inspiration “Aut inveniam viam aut faciam”  Joseph S. Coselli, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume.
Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins 
Historical perspectives of The American Association for Thoracic Surgery: Michael E. DeBakey ( )  Daniel Eads, MD, John S. Ikonomidis, MD, PhD 
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Andreas Rimner, MD, Daniel R. Gomez, MD, Abraham J
Cancer Disparities Research Symposium
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.
Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation 
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG.
Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial 
Gemcitabine and Irinotecan for Patients with Untreated Extensive Stage Small Cell Lung Cancer: SWOG 0119  Wallace Akerley, MD, Jason McCoy, MS, Paul J.
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Electronic Updates for JTO Readers
A-01 TITLE LINE 1 arial font 8; all caps; bold TITLE LINE 2
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
P2.03b-023 Circulating Tumor DNA (ctDNA)-Based Genomic Profiling of Known Cancer Genes in Lung Squamous Cell Carcinoma (LUSC)  Vincent Lam, Hai Tran,
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience  Shulian Wang, MD, Zhongxing.
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective.
Phase II Trial of Carboplatin, Paclitaxel, Cetuximab, and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Nonsquamous Non–Small-Cell Lung.
Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)  Primo N. Lara,
Editorial Staff The Journal of Thoracic and Cardiovascular Surgery
George Blumenschein, MD, John V. Heymach, MD, PhD 
Elizabeth B. Gottlin, PhD, Rex C. Bentley, MD, Michael J
Chemotherapy in Patients ≥80 with Advanced Non-small Cell Lung Cancer: Combined Results from SWOG 0027 and LUN 6  Paul J. Hesketh, MD, Rogerio C. Lilenbaum,
Development of the International Thymic Malignancy Interest Group International Database: An Unprecedented Resource for the Study of a Rare Group of Tumors 
Images in Emergency Medicine
Non–Small-Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment  Gerald S. Falchook, MD,
Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural.
A Translational View of the Molecular Pathogenesis of Lung Cancer
Anne S. Tsao, MD, Suyu Liu, PhD, J. Jack Lee, PhD, Christine M
Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial  Primo N. Lara,
Phase I Study of Lenalidomide in Solid Tumors
Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated.
Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer:
David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W
Linda L. Garland, MD, Kari Chansky, MS, Antoinette J
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival  John P. Griffin, MD, Charles E.
Therapeutic R2 resection for pleural mesothelioma
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A
Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer  Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.
Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M
Robert Comis, MD, The Passing of a “Lung Man”
Presentation transcript:

Andy Futreal, PhD – MD Anderson Cancer Center Baylor College of Medicine / MD Anderson Cancer Center Joint Symposium Thoracic Oncology February 3, 2017 Onstead Auditorium, BSRB 3.8012, George and Cynthia Mitchell Basic Science Research Building 6767 Bertner Ave., Houston, Texas https://docs.google.com/forms/BCM-MDACC Symposium Keynote Speakers Andy Futreal, PhD – MD Anderson Cancer Center Jaffer Ajani, MD – MD Anderson Cancer Center Scott Antonia, MD, PhD – Moffitt Cancer Center David Sugarbaker, MD – Baylor College of Medicine Speakers Paul Cinciripini, PhD – MD Anderson Cancer Center Richard De La Garza, PhD – Baylor College of Medicine Bryan Bur, MD – Baylor College of Medicine Daniel Gomez, MD – MD Anderson Cancer Center James Welsh, MD – MD Anderson Cancer Center John Heymach, MD, PhD – MD Anderson Cancer Center Aaron Thrift, PhD – Baylor College of Medicine Wa Xian, PhD – MD Anderson Cancer Center Wayne Hofstetter, MD – MD Anderson Cancer Center Anne Tsao, MD – MD Anderson Cancer Center Pavan Jhaveri, MD – Baylor College of Medicine Cullen Taniguchi, MD, Register at :